Submission of a manuscript implies that the work described has not been published before (except in form of an abstract or as part of a published lecture, review or thesis), that it is not under consideration for publication elsewhere, and that its publication has been approved by all co-authors, if any, as well as – tacitly or explicitly – by the responsible authorities at the institution where the work was carried out. The author warrants that his/her contribution is original and that he/she has full power to make this grant. The author signs for and accepts responsibility for releasing this material on behalf of any and all co-authors. Transfer of copyright from the authors(s) to the Publisher/Pro Pharma Communications International (PPCI) becomes effective if and when the manuscript is accepted for publication. Accepted papers become the permanent property of GaBI Journal and may not be reproduced by any means, in whole or in part, without the written consent of the Publisher. The Publisher will not be held legally responsible should there be any claims for compensation.
After submission of the copyright transfer form signed by the corresponding author, changes of authorship or in the order of the authors listed will not be accepted by PPCI.
The copyright covers the exclusive right and license to reproduce, publish, distribute and archive the article in all forms and media of expression now known or developed in the future, including reprints, translations, photographic reproductions, microform, electronic form (offline, online) or any other reproductions of similar nature.
All articles published in GaBI Journal are protected by copyright, which covers the exclusive rights to reproduce and distribute the article, e.g. as offprint, as well as all translation rights. No material published in this journal may be reproduced photographically or stored on microfilm, in electronic databases, videodisks, etc., without first obtaining written permission from the Publisher.
The use of general descriptive names, trade names, trademarks, etc., in the manuscript, even if not specifically identified, does not imply that the relevant laws and regulations do not protect these names.
An author may self-archive an author-created version of his/her article on his/her own website. He/she may also deposit this version on his/her institution’s and funder’s (funder designated) repository, including his/her final version, provided it is not made publicly available after official publication. He/she may not use the Publisher’s PDF version, which is posted on www.gabi-journal.net, for the purpose of self-archiving or deposit. Furthermore, the author may only post his/her version provided acknowledgement is given to the original source of publication and a link is inserted to the published article on PPCI’s website. The link must be accompanied by the following text: ‘The original publication is available at www.gabi-journal.net’.
GaBI Journal is a part of
Pro Pharma Communications International
Ownership and copyright
© Copyright hold by GaBI Journal and Pro Pharma Communications International
Source URL: http://gabi-journal.net/gabi-journal/information-for-authors/copyright
Copyright ©2019 GaBI Journal unless otherwise noted.